A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a double-blind, multicenter study involving patients with chronic HCV infection who had a liver transplantation; developed HCV-related liver fibrosis and/or incomplete cirrhosis; achieved a sustained virologic response (SVR) following anti-HCV therapy; but still have fibrosis and/or incomplete cirrhosis on liver biopsy to see if treatment with IDN-6556 is better than placebo in reversing or stopping the progression of the damage to the new liver caused by HCV.
Epistemonikos ID: 1815c7ee74aa5410372506b145f9609291be6f44
First added on: Mar 23, 2020